How to buy Minerva Surgical stock (UTRS)

Minerva Surgical is a medical devices business based in the US. Minerva Surgical shares (UTRS) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Minerva Surgical employs 174 staff and has a trailing 12-month revenue of around $51.7 million.

Our top picks for where to buy Minerva Surgical stock

Buy Minerva Surgical stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Minerva Surgical stock price (PINK: UTRS)

Use our graph to track the performance of UTRS stocks over time.

Minerva Surgical shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$0.00
52-week range	$0.00 - $1.80
50-day moving average more info button	$0.00
200-day moving average more info button	$0.09
Wall St. target price	$3.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-7.61

Minerva Surgical price performance over time

Historical closes compared with the close of $0.0001 from 2024-12-24

1 week (2024-12-20)	0.0001
1 month (2024-11-27)	0.0001
3 months (2024-09-27)	-99.17%
6 months (2024-06-27)	-99.17%

1 year (2023-12-27)	-99.99%
2 years (2022-12-27)	-100.00%
3 years (2021-12-27)	101
5 years (2019-12-23)	N/A

Minerva Surgical financials

Revenue TTM	$51.7 million
Gross profit TTM	$27.2 million
Return on assets TTM	-27.35%
Return on equity TTM	-160.08%
Profit margin	-64.71%
Book value	$2.28
Market Capitalization more info button	$888

TTM: trailing 12 months

Minerva Surgical share dividends

We're not expecting Minerva Surgical to pay a dividend over the next 12 months.

You may also wish to consider:

• CVS Health (CVS.US) (6% forward annual dividend yield)

Have Minerva Surgical's shares ever split?

Minerva Surgical's shares were split on a 1:20 basis on 1 October 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Minerva Surgical shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Minerva Surgical shares which in turn could have impacted Minerva Surgical's share price.

Minerva Surgical share price volatility

Over the last 12 months, Minerva Surgical's shares have ranged in value from as little as $0.0001 up to $1.8. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while Minerva Surgical's is 4.596. This would suggest that Minerva Surgical's shares are significantly more volatile than the average for this exchange and represent a higher risk.

To put Minerva Surgical's beta into context you can compare it against those of similar companies.

• Forward Pharma A S (FWP.US): 1.3811
• CVS Health (CVS.US): 0.543
• Ayala Pharmaceuticals Inc (AYLA.US): 1.9895

Minerva Surgical overview

Minerva Surgical, Inc. , a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California. .

Frequently asked questions

What percentage of Minerva Surgical is owned by insiders or institutions?
Currently 0.425% of Minerva Surgical shares are held by insiders and 68.811% by institutions. How many people work for Minerva Surgical?
Latest data suggests 174 work at Minerva Surgical. When does the fiscal year end for Minerva Surgical?
Minerva Surgical's fiscal year ends in December. Where is Minerva Surgical based?
Minerva Surgical's address is: 4255 Burton Drive, Santa Clara, CA, United States, 95054 What is Minerva Surgical's ISIN number?
Minerva Surgical's international securities identification number is: US60343F1066